This is a Validated Antibody Database (VAD) review about human endostatin, based on 5 published articles (read how Labome selects the articles), using endostatin antibody in all methods. It is aimed to help Labome visitors find the most suited endostatin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
endostatin synonym: KNO; KNO1; KS

Santa Cruz Biotechnology
mouse monoclonal (1837-46)
  • immunohistochemistry; human; 1:100
Santa Cruz Biotechnology endostatin antibody (Santa Cruz Biotechnology, sc-32720) was used in immunohistochemistry on human samples at 1:100. Circ Res (2020) ncbi
mouse monoclonal (1837-46)
  • immunohistochemistry; mouse; 1:100; fig s3
Santa Cruz Biotechnology endostatin antibody (Santa Cruz, sc-32720) was used in immunohistochemistry on mouse samples at 1:100 (fig s3). Matrix Biol (2015) ncbi
Abcam
mouse monoclonal
  • western blot; rat; fig 7
Abcam endostatin antibody (abcam, ab64569) was used in western blot on rat samples (fig 7). BMC Cancer (2016) ncbi
mouse monoclonal
  • western blot; human; fig s4
In order to characterize D-2-hydroxyglutarate in its oncogenic property of mutant IDH-containing cancer cells but is dispensable for cell growth, Abcam endostatin antibody (Abcam, ab64569) was used in western blot on human samples (fig s4). Oncotarget (2015) ncbi
Invitrogen
mouse monoclonal (1837-46)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human; 1:50
In order to study the immunohistochemistry of non-small cell lung cancer, Invitrogen endostatin antibody (NeoMarkers, 1837-46) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples at 1:50. J Korean Med Sci (2007) ncbi
Articles Reviewed
  1. Vaisar T, Hu J, Airhart N, Fox K, Heinecke J, Nicosia R, et al. Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture. Circ Res. 2020;127:997-1022 pubmed publisher
  2. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed publisher
  3. Ma S, Jiang B, Deng W, Gu Z, Wu F, Li T, et al. D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth. Oncotarget. 2015;6:8606-20 pubmed
  4. Besschetnova T, Ichimura T, Katebi N, St Croix B, Bonventre J, Olsen B. Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis. Matrix Biol. 2015;42:56-73 pubmed publisher
  5. Yoo J, Jung J, Lee M, Seo K, Shim B, Kim S, et al. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci. 2007;22:318-25 pubmed